HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lack of association between MnSOD Val16Ala polymorphism and breast cancer risk: a meta-analysis involving 58,448 subjects.

Abstract
Published data on the association between MnSOD Val16Ala polymorphism and breast cancer risk are inconclusive. To derive a more precise estimation of the relationship, a meta-analysis was performed. Medline, PubMed, Embase, and Web of Science were searched. Crude ORs with 95% CIs were used to assess the strength of association between the MnSOD Val16Ala polymorphism and breast cancer risk. The pooled ORs were performed for co-dominant model (Val/Ala vs. Val/Val, Ala/Ala vs. Val/Val), dominant model (Ala/Ala + Val/Ala vs. Val/Val), and recessive model (Ala/Ala vs. Val/Ala + Val/Val), respectively. A total of 32 studies including 26,022 cases and 32,426 controls were involved in this meta-analysis. Overall, no significant associations were found between MnSOD Val16Ala polymorphism and breast cancer risk when all studies pooled into the meta-analysis (Val/Ala vs. Val/Val: OR = 1.022, 95% CI = 0.981-1.064; Ala/Ala vs. Val/Val: OR = 1.006, 95% CI = 0.934-1.083; dominant model: OR = 1.013, 95% CI = 0.962-1.066; and recessive model: OR = 0.985, 95% CI = 0.931-1.042). In the subgroup analysis by ethnicity or study design, still no significant associations were found for all comparison models. In conclusion, this meta-analysis suggests that the MnSOD Val16Ala polymorphism may be not associated with breast cancer development. However, large sample and representative population-based studies with homogeneous breast cancer patients and well-matched controls are warranted to confirm this finding.
AuthorsLi-Xin Qiu, Lei Yao, Chen Mao, Bo Chen, Ping Zhan, Hui Yuan, Kai Xue, Jian Zhang, Xi-Chun Hu
JournalBreast cancer research and treatment (Breast Cancer Res Treat) Vol. 123 Issue 2 Pg. 543-7 (Sep 2010) ISSN: 1573-7217 [Electronic] Netherlands
PMID20143154 (Publication Type: Journal Article, Meta-Analysis)
Chemical References
  • Superoxide Dismutase
  • superoxide dismutase 2
Topics
  • Breast Neoplasms (enzymology, genetics)
  • Case-Control Studies
  • Female
  • Genetic Predisposition to Disease
  • Humans
  • Linear Models
  • Odds Ratio
  • Phenotype
  • Polymorphism, Genetic
  • Risk Assessment
  • Risk Factors
  • Superoxide Dismutase (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: